|Mr. Marc Denham Loomes BVSc, MRCVS||CEO & Exec. Director||N/A||N/A||56|
|Mr. Kevin Anthony Stockdale BSc, ACA||Fin. Director & Exec. Director||N/A||N/A||52|
|Mr. Brett Clemo BA (Hons)||Exec. Director||N/A||N/A||N/A|
|Mrs. Julia Trouse||Sec. & Exec. Director||N/A||N/A||N/A|
|Mr. Peter A. Lawrence B Eng (Hons), C Eng, MBA, MSc, BSc, DIC, ACGI||Exec. Chairman||62.24k||N/A||68|
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.
ECO Animal Health Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.